{"groups":[{"description":"Patients receive oral treatment with olaparib 300mg twice daily in combination with abiraterone 1000mg once daily","id":"FG000","title":"Olaparib 300 mg bd + Abiraterone 1000 mg qd"},{"description":"Patients receive oral treatment with placebo twice daily in combination with abiraterone 1000mg once daily.","id":"FG001","title":"Placebo bd + Abiraterone 1000 mg qd"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"168"},{"groupId":"FG001","numSubjects":"203"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"}],"type":"Other"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"Failure to meet randomisation criteria"},{"reasons":[{"groupId":"FG000","numSubjects":"14"},{"groupId":"FG001","numSubjects":"10"}],"type":"Patient decision"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}],"type":"Screen failure"},{"reasons":[{"groupId":"FG000","numSubjects":"210"},{"groupId":"FG001","numSubjects":"178"}],"type":"Patients ongoing study at data cut off"},{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"2"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"399"},{"groupId":"FG001","numSubjects":"397"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"399"},{"groupId":"FG001","numSubjects":"397"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}